Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity RatioInvested Capital

Alterity Therapeutics (ATHE) Equity Ratio (2016 - 2025)

Alterity Therapeutics has reported Equity Ratio over the past 4 years, most recently at 0.83 for Q2 2019.

  • For Q2 2019, Equity Ratio fell 3.18% year-over-year to 0.83; the TTM value through Jun 2019 reached 0.83, down 3.18%, while the annual FY2019 figure was 0.83, 3.18% down from the prior year.
  • Equity Ratio for Q2 2019 was 0.83 at Alterity Therapeutics, down from 0.86 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.86 in Q2 2018 and troughed at 0.0 in Q2 2016.
  • A 4-year average of 0.42 and a median of 0.42 in 2017 define the central range for Equity Ratio.
  • Biggest five-year swings in Equity Ratio: surged 91542.9% in 2018 and later dropped 3.18% in 2019.
  • Year by year, Equity Ratio stood at 0.0 in 2016, then grew by 0.75% to 0.0 in 2017, then soared by 91542.9% to 0.86 in 2018, then decreased by 3.18% to 0.83 in 2019.
  • Business Quant data shows Equity Ratio for ATHE at 0.83 in Q2 2019, 0.86 in Q2 2018, and 0.0 in Q2 2017.